NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
1.820
+0.020 (1.11%)
Feb 18, 2026, 2:23 PM EST - Market open
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $53.88 million as of February 18, 2026. Its market cap has increased by 47.62% in one year.
Market Cap
53.88M
Enterprise Value
57.69M
1-Year Change
47.62%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has decreased from $65.80M to $53.88M, a decrease of -18.11%. That is a compound annual growth rate of -2.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 50.60M | -33.51% |
| Dec 31, 2025 | 76.10M | 186.09% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
| Nov 20, 2017 | 65.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuCell | 57.26M |
| Kazia Therapeutics | 57.21M |
| PMV Pharmaceuticals | 56.94M |
| TScan Therapeutics | 56.41M |
| Metagenomi Therapeutics | 55.19M |
| Radiopharm Theranostics | 55.08M |
| Tevogen Bio Holdings | 54.23M |
| BeyondSpring | 52.64M |